Skip to main content

Novartis Picks GeneData for Software Platform Build-out

NEW YORK, Jan. 23 - GeneData said today that it is working with Novartis to help the pharmaceutical company build an integrated software platform for data visualization and analysis.


The computational data analysis platform will help to analyze and visualize high throughput screening and compound profiling data, assess data quality, and perform large-scale compound profiling, according to GeneData.


Novartis has licensed GeneData's Screener software system as part of the multi-year deal.


Financial details of the agreement were not disclosed.


The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.